Krystal Biotech, Inc. (KRYS)

Krystal Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 28, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,905	4,506	3,499	2,040	1,742	1,182
Market Cap Growth	28.76%	28.76%	71.56%	17.08%	47.34%	23.36%
Enterprise Value	4,163	3,819	2,909	1,642	1,388	899
Last Close Price	169.73	156.66	124.06	79.22	69.95	60.00
PE Ratio	56.58	50.54	320.10	-	-	-
Forward PE	25.60	33.31	-	-	-	-
PS Ratio	16.70	15.51	69.02	-	-	-
PB Ratio	5.16	4.76	4.49	3.91	2.94	4.05
P/TBV Ratio	5.18	4.76	4.49	3.91	2.94	4.05
P/FCF Ratio	41.15	37.81	-	-	-	-
P/OCF Ratio	39.74	36.51	-	-	-	-
EV/Sales Ratio	14.33	13.15	57.38	-	-	-
EV/EBITDA Ratio	39.40	36.14	-	-	-	-
EV/EBIT Ratio	40.34	37.01	-	-	-	-
EV/FCF Ratio	34.93	32.04	-	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.02	0.01	0.01
Debt / EBITDA Ratio	0.07	0.07	-	-	-	-
Debt / FCF Ratio	0.06	0.06	-	-	-	-
Asset Turnover	0.31	0.31	0.07	-	-	-
Inventory Turnover	1.20	1.20	-	-	-	-
Quick Ratio	6.89	6.89	17.35	13.14	17.02	17.56
Current Ratio	7.28	7.28	17.77	13.30	17.18	17.80
Return on Equity (ROE)	10.34%	10.34%	1.68%	-25.09%	-15.71%	-13.00%
Return on Assets (ROA)	6.88%	6.88%	-8.83%	-12.80%	-9.32%	-7.93%
Return on Capital (ROIC)	7.41%	7.41%	-9.22%	-13.38%	-9.73%	-8.21%
Return on Capital Employed (ROCE)	10.80%	10.80%	-	-	-	-
Earnings Yield	1.82%	1.98%	0.31%	-6.86%	-3.99%	-2.72%
FCF Yield	2.43%	2.65%	-2.88%	-7.53%	-6.67%	-3.46%
Buyback Yield / Dilution	-7.16%	-7.16%	-8.87%	-14.85%	-18.15%	-18.15%

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q